Filing Details
- Accession Number:
- 0001104659-12-057435
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-13 18:00:55
- Reporting Period:
- 2012-08-09
- Filing Date:
- 2012-08-13
- Accepted Time:
- 2012-08-13 18:00:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1180469 | Ernest Mario | 1172 Castro Street Mountain View CA 94040 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-08-09 | 15,000 | $21.83 | 35,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2012-08-10 | 5,000 | $21.50 | 40,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchase price reported in Column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $21.75 to $21.929 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.